Eli Lilly and Comp. (LLY) stock Forecast for 2022 – 2026
Last update: 05-20-2022, 8:38
Sector: HealthcareThe share price of Eli Lilly and Company (LLY) now
What analysts predict:: $304.28
52-week high/low: $312.95 / $192.79
50/200 Day Moving Average: $289.45 / $260.85
This figure corresponds to the average price over the previous 50/200 days. For Eli Lilly and Comp. stocks, the 50-day moving average is the resistance level today.
For Eli Lilly and Comp. stocks, the 200-day moving average is the support level today.
Are you interested in Eli Lilly and Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Eli Lilly and Comp. stock price in 2022, 2023, 2024, 2025, 2026. How much will one Eli Lilly and Comp. share be worth in 2022 - 2026?
When should I take profit in Eli Lilly and Comp. stock? When should I record a loss on Eli Lilly and Comp. stock? What are analysts' forecasts for Eli Lilly and Comp. stock? What is the future of Eli Lilly and Comp. stock?
We forecast Eli Lilly and Comp. stock performance using neural networks based on historical data on Eli Lilly and Comp. stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Eli Lilly and Comp. stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Eli Lilly and Comp. shares. This happens once a day.
Historical and forecast chart of Eli Lilly and Comp. stock
The chart below shows the historical price of Eli Lilly and Comp. stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Eli Lilly and Comp. stock price can be found in the table below.
Long-term forecasts by years.
Eli Lilly and Comp. daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 22 | 285.74 | 282.57 | 291.40 | 3.12 |
| May 23 | 288.82 | 283.11 | 291.34 | 2.91 |
| May 24 | 281.46 | 274.79 | 283.91 | 3.32 |
| May 25 | 273.94 | 269.59 | 275.83 | 2.32 |
| May 26 | 280.68 | 274.12 | 286.24 | 4.42 |
| May 27 | 277.57 | 275.90 | 282.90 | 2.53 |
| May 28 | 278.40 | 276.23 | 281.07 | 1.75 |
| May 29 | 281.07 | 277.95 | 283.86 | 2.12 |
| May 30 | 282.93 | 277.75 | 285.30 | 2.72 |
| May 31 | 276.14 | 274.32 | 279.37 | 1.84 |
| Jun 01 | 275.81 | 269.35 | 278.95 | 3.56 |
| Jun 02 | 279.45 | 275.67 | 285.82 | 3.68 |
| Jun 03 | 284.48 | 280.30 | 287.38 | 2.53 |
| Jun 04 | 291.22 | 286.85 | 298.03 | 3.90 |
| Jun 05 | 297.77 | 292.23 | 302.95 | 3.67 |
| Jun 06 | 301.97 | 295.72 | 308.76 | 4.41 |
| Jun 07 | 303.87 | 298.04 | 309.52 | 3.85 |
| Jun 08 | 301.87 | 296.43 | 306.94 | 3.54 |
| Jun 09 | 301.50 | 299.33 | 306.03 | 2.24 |
| Jun 10 | 297.89 | 295.56 | 304.86 | 3.14 |
| Jun 11 | 294.85 | 289.45 | 301.84 | 4.28 |
| Jun 12 | 296.79 | 291.18 | 300.27 | 3.12 |
| Jun 13 | 298.84 | 295.52 | 304.31 | 2.97 |
| Jun 14 | 304.67 | 302.57 | 311.89 | 3.08 |
| Jun 15 | 305.58 | 302.83 | 312.00 | 3.03 |
| Jun 16 | 309.53 | 306.93 | 312.40 | 1.79 |
| Jun 17 | 313.89 | 307.96 | 318.69 | 3.49 |
| Jun 18 | 316.43 | 314.15 | 322.51 | 2.66 |
| Jun 19 | 319.19 | 316.41 | 325.70 | 2.94 |
| Jun 20 | 311.72 | 308.82 | 315.46 | 2.15 |
Eli Lilly and Comp. Daily Price Targets
Eli Lilly and Comp. Stock Forecast 05-22-2022.
Pessimistic target level: 282.57
Optimistic target level: 291.40
Eli Lilly and Comp. Stock Forecast 05-23-2022.
Pessimistic target level: 283.11
Optimistic target level: 291.34
Eli Lilly and Comp. Stock Forecast 05-24-2022.
Pessimistic target level: 274.79
Optimistic target level: 283.91
Eli Lilly and Comp. Stock Forecast 05-25-2022.
Pessimistic target level: 269.59
Optimistic target level: 275.83
Eli Lilly and Comp. Stock Forecast 05-26-2022.
Pessimistic target level: 274.12
Optimistic target level: 286.24
Eli Lilly and Comp. Stock Forecast 05-27-2022.
Pessimistic target level: 275.90
Optimistic target level: 282.90
LLY (LLY) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 280.22 | 254.00 | 298.44 | 14.89 |
| Jul. | 263.10 | 243.61 | 277.13 | 12.10 |
| Aug. | 255.24 | 229.36 | 276.47 | 17.04 |
| Sep. | 242.63 | 223.70 | 249.25 | 10.25 |
| Oct. | 223.70 | 215.85 | 240.86 | 10.38 |
| Nov. | 251.91 | 243.07 | 258.46 | 5.95 |
| Dec. | 282.04 | 255.64 | 296.71 | 13.84 |
Eli Lilly and Comp. forecast for this year
Eli Lilly and Comp. Stock Prediction for Jun 2022
An downtrend is forecast for this month with an optimal target price of $280.224. Pessimistic: $254.00. Optimistic: $298.44
Eli Lilly and Comp. Stock Prediction for Jul 2022
An downtrend is forecast for this month with an optimal target price of $263.102. Pessimistic: $243.61. Optimistic: $277.13
Eli Lilly and Comp. Stock Prediction for Aug 2022
An downtrend is forecast for this month with an optimal target price of $255.235. Pessimistic: $229.36. Optimistic: $276.47
Eli Lilly and Comp. Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $242.627. Pessimistic: $223.70. Optimistic: $249.25
Eli Lilly and Comp. Stock Prediction for Oct 2022
An downtrend is forecast for this month with an optimal target price of $223.702. Pessimistic: $215.85. Optimistic: $240.86
Eli Lilly and Comp. Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $251.911. Pessimistic: $243.07. Optimistic: $258.46
Eli Lilly and Comp. Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $282.039. Pessimistic: $255.64. Optimistic: $296.71
Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 263.71 | 237.31 | 277.42 | 14.46 |
| Feb | 261.31 | 244.66 | 285.77 | 14.38 |
| Mar | 285.09 | 274.71 | 296.95 | 7.49 |
| Apr | 297.69 | 271.37 | 315.49 | 13.98 |
| May | 294.20 | 263.61 | 309.50 | 14.83 |
| Jun | 332.45 | 304.79 | 349.31 | 12.74 |
| Jul | 317.32 | 290.51 | 344.96 | 15.79 |
| Aug | 302.47 | 275.73 | 317.81 | 13.24 |
| Sep | 335.50 | 325.04 | 347.28 | 6.41 |
| Oct | 316.31 | 283.83 | 348.80 | 18.63 |
| Nov | 340.16 | 304.79 | 365.37 | 16.58 |
| Dec | 364.93 | 335.99 | 393.87 | 14.69 |
Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 351.17 | 320.58 | 364.41 | 12.03 |
| Feb | 365.32 | 350.12 | 387.17 | 9.57 |
| Mar | 382.42 | 345.63 | 393.85 | 12.24 |
| Apr | 347.62 | 313.27 | 372.47 | 15.89 |
| May | 377.44 | 343.10 | 404.43 | 15.17 |
| Jun | 403.94 | 374.53 | 417.59 | 10.31 |
| Jul | 454.35 | 437.81 | 486.84 | 10.07 |
| Aug | 451.99 | 438.47 | 472.55 | 7.21 |
| Sep | 404.98 | 382.87 | 441.84 | 13.35 |
| Oct | 379.71 | 345.16 | 400.44 | 13.81 |
| Nov | 344.66 | 327.64 | 359.90 | 8.96 |
| Dec | 334.81 | 315.22 | 349.61 | 9.84 |
Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 367.89 | 347.32 | 401.84 | 13.57 |
| Feb | 409.49 | 396.72 | 435.05 | 8.81 |
| Mar | 394.59 | 356.12 | 431.52 | 17.47 |
| Apr | 444.86 | 399.75 | 469.15 | 14.79 |
| May | 440.81 | 426.48 | 483.22 | 11.74 |
| Jun | 466.60 | 418.68 | 493.89 | 15.23 |
| Jul | 460.53 | 415.03 | 505.43 | 17.89 |
| Aug | 444.97 | 422.41 | 479.67 | 11.94 |
| Sep | 410.26 | 380.92 | 443.33 | 14.08 |
| Oct | 381.99 | 348.22 | 414.27 | 15.94 |
| Nov | 400.37 | 373.82 | 426.91 | 12.44 |
| Dec | 387.87 | 358.12 | 415.10 | 13.73 |
Eli Lilly and Comp. (LLY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 392.41 | 363.33 | 430.16 | 15.54 |
| Feb | 399.04 | 377.26 | 433.28 | 12.93 |
| Mar | 379.33 | 366.51 | 389.69 | 5.95 |
| Apr | 414.84 | 391.11 | 449.89 | 13.07 |
| May | 404.59 | 364.09 | 431.94 | 15.71 |
| Jun | 411.43 | 394.31 | 425.87 | 7.41 |
| Jul | 391.64 | 361.60 | 405.38 | 10.80 |
| Aug | 429.82 | 408.59 | 447.14 | 8.62 |
| Sep | 438.76 | 399.98 | 458.16 | 12.70 |
| Oct | 462.72 | 441.06 | 474.75 | 7.10 |
| Nov | 471.74 | 451.50 | 499.34 | 9.58 |
| Dec | 455.80 | 425.58 | 480.68 | 11.46 |
Eli Lilly and Comp. information and performance
Eli Lilly and Company is an American pharmaceutical company. It was founded in 1876 in Indianapolis, Indiana, where its headquarters are still located. It is known as the first company to start the industrial production of insulin (in 1923). The company operates in two areas: medicines for humans and veterinary medicines (a division of Elanco). The company’s products are sold in 120 countries.
Eli Lilly and Comp. Address
LILLY CORPORATE CTR, DROP CODE 1112, INDIANAPOLIS, IN, US
Market Capitalization: 286 378 230 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 10 721 400 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 44.8
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 1.833
Price/earnings to growth
DPS: 3.53
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: 0.0134
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 6.73
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: 0.409
Quarterly Revenue Growth YOY: 0.148
Trailing PE: 44.8
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 34.72
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 9.93
Enterprise Value (EV) /Revenue
EV To EBITDA: 33.44
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 950160000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Eli Lilly and Comp. (LLY) stock dividend
Eli Lilly and Comp. last paid dividends on 05/13/2022. The next scheduled payment will be on 06/10/2022. The amount of dividends is $3.53 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.